Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
ELSE vs SIFY vs FLUX vs HCTI vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Electrical Equipment & Parts
Medical - Healthcare Information Services
Software - Infrastructure
ELSE vs SIFY vs FLUX vs HCTI vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Telecommunications Services | Electrical Equipment & Parts | Medical - Healthcare Information Services | Software - Infrastructure |
| Market Cap | $27M | $1.18B | $18M | $48K | $3.08T |
| Revenue (TTM) | $10M | $41.45B | $51M | $13M | $318.27B |
| Net Income (TTM) | $404K | $-1.50B | $-6M | $-6M | $125.22B |
| Gross Margin | 50.7% | 34.2% | 32.1% | 13.1% | 68.3% |
| Operating Margin | 0.4% | 5.2% | -1.9% | -45.2% | 46.8% |
| Forward P/E | 58.7x | — | — | — | 24.8x |
| Total Debt | $0.00 | $39.51B | $16M | $3M | $112.18B |
| Cash & Equiv. | $10M | $5.00B | $1M | $20K | $30.24B |
ELSE vs SIFY vs FLUX vs HCTI vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Electro-Sensors, In… (ELSE) | 100 | 148.2 | +48.2% |
| Sify Technologies L… (SIFY) | 100 | 76.5 | -23.5% |
| Flux Power Holdings… (FLUX) | 100 | 17.6 | -82.4% |
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
| Microsoft Corporati… (MSFT) | 100 | 125.2 | +25.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELSE vs SIFY vs FLUX vs HCTI vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELSE is the #2 pick in this set and the best alternative if stability is your priority.
- Beta 0.02 vs HCTI's 3.25
SIFY ranks third and is worth considering specifically for momentum.
- +273.9% vs HCTI's -99.9%
FLUX lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, HCTI doesn't own a clear edge in any measured category.
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 19 yrs, beta 0.85, yield 0.8%
- Rev growth 14.9%, EPS growth 15.6%, 3Y rev CAGR 12.4%
- 7.8% 10Y total return vs SIFY's 147.9%
- Lower volatility, beta 0.85, Low D/E 32.7%, current ratio 1.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.9% revenue growth vs HCTI's -64.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 39.3% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.02 vs HCTI's 3.25 | |
| Dividends | 0.8% yield, 19-year raise streak, vs SIFY's 0.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +273.9% vs HCTI's -99.9% | |
| Efficiency (ROA) | 19.2% ROA vs HCTI's -60.0%, ROIC 24.9% vs -6.3% |
ELSE vs SIFY vs FLUX vs HCTI vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ELSE vs SIFY vs FLUX vs HCTI vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 3 of 6 categories
SIFY leads 1 • ELSE leads 1 • FLUX leads 0 • HCTI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSFT is the larger business by revenue, generating $318.3B annually — 32520.0x ELSE's $10M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $10M | $41.4B | $51M | $13M | $318.3B |
| EBITDAEarnings before interest/tax | $130,000 | $8.1B | -$212,000 | -$6M | $192.6B |
| Net IncomeAfter-tax profit | $404,000 | -$1.5B | -$6M | -$6M | $125.2B |
| Free Cash FlowCash after capex | $325,000 | $0 | -$7M | -$12M | $72.9B |
| Gross MarginGross profit ÷ Revenue | +50.7% | +34.2% | +32.1% | +13.1% | +68.3% |
| Operating MarginEBIT ÷ Revenue | +0.4% | +5.2% | -1.9% | -45.2% | +46.8% |
| Net MarginNet income ÷ Revenue | +4.1% | -3.6% | -12.5% | -48.9% | +39.3% |
| FCF MarginFCF ÷ Revenue | +3.3% | -9.2% | -14.7% | -94.7% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.4% | +2.5% | -60.6% | +44.6% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -13.4% | -3.7% | -25.0% | -63.8% | +23.4% |
Valuation Metrics
Evenly matched — SIFY and MSFT each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 30.4x trailing earnings, MSFT trades at a 48% valuation discount to ELSE's 58.7x P/E. Adjusting for growth (PEG ratio), MSFT offers better value at 1.62x vs ELSE's 3.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $27M | $1.2B | $18M | $47,905 | $3.08T |
| Enterprise ValueMkt cap + debt − cash | $17M | $1.5B | $32M | $3M | $3.17T |
| Trailing P/EPrice ÷ TTM EPS | 58.69x | -122.55x | -2.52x | -0.01x | 30.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | 24.77x |
| PEG RatioP/E ÷ EPS growth rate | 3.13x | — | — | — | 1.62x |
| EV / EBITDAEnterprise value multiple | 188.73x | 18.53x | — | — | 19.46x |
| Price / SalesMarket cap ÷ Revenue | 2.83x | 2.80x | 0.27x | 0.00x | 10.94x |
| Price / BookPrice ÷ Book value/share | 1.83x | 4.77x | — | — | 9.02x |
| Price / FCFMarket cap ÷ FCF | 340.47x | — | — | — | 43.06x |
Profitability & Efficiency
MSFT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-7 for FLUX. MSFT carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to SIFY's 1.96x. On the Piotroski fundamental quality scale (0–9), FLUX scores 6/9 vs HCTI's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.8% | -7.7% | -7.4% | -112.9% | +33.1% |
| ROA (TTM)Return on assets | +2.7% | -1.8% | -21.0% | -60.0% | +19.2% |
| ROICReturn on invested capital | -0.1% | +3.3% | -30.1% | -6.3% | +24.9% |
| ROCEReturn on capital employed | -0.0% | +4.4% | — | — | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 6 | 3 | 6 |
| Debt / EquityFinancial leverage | — | 1.96x | — | — | 0.33x |
| Net DebtTotal debt minus cash | -$10M | $34.5B | $15M | $3M | $81.9B |
| Cash & Equiv.Liquid assets | $10M | $5.0B | $1M | $20,000 | $30.2B |
| Total DebtShort + long-term debt | $0 | $39.5B | $16M | $3M | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | 66.50x | 0.82x | -1.19x | -3.79x | 55.65x |
Total Returns (Dividends Reinvested)
SIFY leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,377 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, SIFY leads with a +273.9% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors SIFY at 30.0% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +81.7% | +33.0% | -28.9% | -93.8% | -12.0% |
| 1-Year ReturnPast 12 months | +93.7% | +273.9% | -48.7% | -99.9% | -4.5% |
| 3-Year ReturnCumulative with dividends | +69.6% | +119.6% | -73.7% | -100.0% | +37.6% |
| 5-Year ReturnCumulative with dividends | +72.6% | -9.2% | -88.4% | -100.0% | +73.8% |
| 10-Year ReturnCumulative with dividends | +137.7% | +147.9% | -76.0% | -100.0% | +776.0% |
| CAGR (3Y)Annualised 3-year return | +19.2% | +30.0% | -35.9% | -96.0% | +11.2% |
Risk & Volatility
ELSE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ELSE is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than HCTI's 3.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ELSE currently trades 99.6% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.02x | 1.35x | 2.23x | 3.25x | 0.85x |
| 52-Week HighHighest price in past year | $7.66 | $17.85 | $7.55 | $7410.00 | $555.45 |
| 52-Week LowLowest price in past year | $3.65 | $4.15 | $0.91 | $0.29 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +99.6% | +91.5% | +13.4% | +0.0% | +74.7% |
| RSI (14)Momentum oscillator 0–100 | 87.0 | 61.2 | 54.8 | 35.4 | 57.9 |
| Avg Volume (50D)Average daily shares traded | 15K | 57K | 127K | 285K | 32.5M |
Analyst Outlook
MSFT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SIFY as "Buy", MSFT as "Buy". MSFT is the only dividend payer here at 0.78% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | — | — | Buy |
| Price TargetConsensus 12-month target | — | — | — | — | $556.88 |
| # AnalystsCovering analysts | — | 1 | — | — | 81 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | — | — | +0.8% |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | — | 19 |
| Dividend / ShareAnnual DPS | — | $0.36 | — | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +0.6% |
MSFT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SIFY leads in 1 (Total Returns). 1 tied.
ELSE vs SIFY vs FLUX vs HCTI vs MSFT: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is ELSE or SIFY or FLUX or HCTI or MSFT a better buy right now?
For growth investors, Microsoft Corporation (MSFT) is the stronger pick with 14.
9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Microsoft Corporation (MSFT) offers the better valuation at 30. 4x trailing P/E (24. 8x forward), making it the more compelling value choice. Analysts rate Sify Technologies Limited (SIFY) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ELSE or SIFY or FLUX or HCTI or MSFT?
On trailing P/E, Microsoft Corporation (MSFT) is the cheapest at 30.
4x versus Electro-Sensors, Inc. at 58. 7x.
03Which is the better long-term investment — ELSE or SIFY or FLUX or HCTI or MSFT?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +73.
8%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: MSFT returned +776. 0% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ELSE or SIFY or FLUX or HCTI or MSFT?
By beta (market sensitivity over 5 years), Electro-Sensors, Inc.
(ELSE) is the lower-risk stock at 0. 02β versus Healthcare Triangle, Inc. 's 3. 25β — meaning HCTI is approximately 13072% more volatile than ELSE relative to the S&P 500. On balance sheet safety, Microsoft Corporation (MSFT) carries a lower debt/equity ratio of 33% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — ELSE or SIFY or FLUX or HCTI or MSFT?
By revenue growth (latest reported year), Microsoft Corporation (MSFT) is pulling ahead at 14.
9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Electro-Sensors, Inc. grew EPS 62. 1% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, FLUX leads at 16. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ELSE or SIFY or FLUX or HCTI or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — MSFT leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — ELSE or SIFY or FLUX or HCTI or MSFT?
In this comparison, MSFT (0.
8% yield) pays a dividend. ELSE, SIFY, FLUX, HCTI do not pay a meaningful dividend and should not be held primarily for income.
08Is ELSE or SIFY or FLUX or HCTI or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
85), 0. 8% yield, +776. 0% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +776. 0%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ELSE and SIFY and FLUX and HCTI and MSFT?
These companies operate in different sectors (ELSE (Technology) and SIFY (Communication Services) and FLUX (Industrials) and HCTI (Healthcare) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
MSFT pays a dividend while ELSE, SIFY, FLUX, HCTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.